Wearable continuous renal replacement therapy device

Details Wearable continuous renal replacement therapy device Wearable continuous renal replacement therapy device

2011-03-01

2011-03-01

Deak, Leslie (Department: 3761)

Surgery

Blood drawn and replaced or treated and returned to body

Constituent removed from blood and remainder returned to body

C210S646000, C210S645000, C210S739000, C604S006090, C604S006110

Reexamination Certificate

active

07896829

ABSTRACT:
A continuous renal replacement therapy (CRRT) device adapted to be worn on a portion of the body of a patient. The CRRT device is worn by the patient and operates on rechargeable batteries for more than 5 hours. Dialysate is used to remove impurities from the blood. The dialysate is recycled and refreshed by a filter section. Less than one liter of dialysate is required to circulate through the wearable CRRT device.

REFERENCES:
patent: 3388803 (1968-06-01), Scott
patent: 3746175 (1973-06-01), Markley
patent: 3884808 (1975-05-01), Scott
patent: 3884808 (1975-05-01), Scott
patent: 3989622 (1976-11-01), Marantz et al.
patent: 3994799 (1976-11-01), Yao et al.
patent: 4094775 (1978-06-01), Mueller
patent: 4212738 (1980-07-01), Henne
patent: 4247393 (1981-01-01), Wallace
patent: 4267040 (1981-05-01), Schal
patent: 4269708 (1981-05-01), Bonomini et al.
patent: 4443333 (1984-04-01), Mahurkar
patent: 4765907 (1988-08-01), Scott
patent: 4897189 (1990-01-01), Greenwood et al.
patent: 4897189 (1990-01-01), Greenwood et al.
patent: 4968422 (1990-11-01), Runge et al.
patent: 4997570 (1991-03-01), Polaschegg
patent: 5151082 (1992-09-01), Gorsuch et al.
patent: 5284470 (1994-02-01), Beltz
patent: 5415532 (1995-05-01), Loughnane et al.
patent: 5577891 (1996-11-01), Loughnane et al.
patent: 5577891 (1996-11-01), Loughnane et al.
patent: 5902336 (1999-05-01), Mishkin
patent: 5944684 (1999-08-01), Roberts et al.
patent: 5980481 (1999-11-01), Gorsuch
patent: 5984891 (1999-11-01), Keilman et al.
patent: 6117100 (2000-09-01), Powers et al.
patent: 6117122 (2000-09-01), Din et al.
patent: 6196992 (2001-03-01), Keilman et al.
patent: 6332985 (2001-12-01), Sherman et al.
patent: 6406631 (2002-06-01), Collins et al.
patent: 6561997 (2003-05-01), Weitzel et al.
patent: 6796955 (2004-09-01), O'Mahony et al.
patent: 2002/0123712 (2002-09-01), Gorsuch et al.
Shettigar, et al, “A portable hemodialysis/hemofiltration system independent of dialysate and infusion fluid.” Artif Organs, vol. 7, No. 2, May 1983, pp. 254-256.
Manns, Markus et al, “The acu-men: A New Device for Continuous Renal Replacement Therapy in Acute Renal Failure,” Kidney International, vol. 54, 1998, pp. 268-274.
Lockridge, R.S. Jr., “The Direction of End-Stage Renal Disease Reimbursement in the United States,” Semin Dial, vol. 17, 2004, pp. 125-130.
Lockridge, R.S. Jr., et al, “Is HCFA's Reimbursement Policy Controlling Quality of Care for End-State Renal Disease Patients?” ASAIO J, vol. 47, 2001, pp. 466-468.
Manns, B.J. et al, “Dialysis Adequacy and Health Related Quality of Life in Hemodialysis Patients,” ASAIO J, vol. 48, 2002, pp. 565-569.
Mapes, D.L. et al, “Health-related Quality of Life as a Predictor of Mortality and Hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS),” Kidney Int., vol. 64, 2003, pp. 339-349.
McFarlane, P.A. et al, “The Quality of Life and Cost Utility of Home Nocturnal and Conventional In-center Hemodialysis,” Kidney Int., vol. 64, 2003, pp. 1004-1011.
Mohr, P. E., et al, “The Case for Daily Dialysis: Its Impact on Costs and Quality of Life,” Am J Kidney Dis., vol. 37, 2001, pp. 777-789.
Patel, S. S., et al, “Psychosocial Variables, Quality of Life, and Religious Beliefs in ESRD Patients Treated with Hemodialysis,” Am J Kidney Dis., vol. 40, 2002, pp. 1013-1022.
“Sorbent Dialysis Primer,” Organon Teknika Corp., 1991.
Ronco, C., et al, “Blood and Dialysate Flow Distribution in Hollow-fiber Hemodialyzers Analyzed by Computerized Helical Scanning Technique,” J Am Soc Nephrol, vol. 13, 2002, pp. S53-S61.
Mineshima, M., et al, “Effects of Internal Filtration on the Solute Removal Efficiency of a Dialyzer.” ASAIO J, vol. 46, 2000, pp. 456-460.
Ronco, C., et al, “The Hemodialysis System: Basic Mechanisms of Water And Solute Transport in Extracorporeal Renal Replacement Therapies,” Nephrol Dial Transplant, vol. 13 Suppl. 6, 1998, pp. 3-9.
Miwa, M. et al, “Push/Pull Hemodiafiltration: Technical Aspects and Clinical Effectiveness,” Artif Organs, vol. 23, 1999, pp. 1123-1128.
Runge, T.M., et al, “Hemodialysis: Evidence of Enhanced Molecular Clearance and Ultrafiltration Volume by Using Pulsatile Flow,” Int J Artif Organs, vol. 16, 1993, pp. 645-652.
Ding, L. H., et al, “Dynamic filtration of Blood: A New Concept For Enhancing Plasma Filtration,” Int J Artif Organs, vol. 14, 1991, pp. 365-370.
Bird, R. B., et al, Transport Phenomena, Wiley, New York, 1976, pp. 126-130, 502-531, 558-563, 624-625, 700-711.
Welty, J. R., et al, “Chapter 27: Unsteady-state Molecular Diffusion,” Fundamentals of Momentum, Heat, and Mass Transfer (2nd ed.), McGraw-Hill, New York, 1984.
Siaghy, E. M., et al, “Consequences of Static and Pulsatile on Transmembrane Exchanges During Vitro Microdialysis: Implication for Studies in Cardiac Physiology,” Med Biol Eng Comput, vol. 37, 1999, pp. 196-201.
Utsunomiya, T., et al, “Effect of Direct Pulsatile Peritoneal Dialysis on Peritoneal Permeability and Lymphatic Absorption in the Rat,” Nippon Jinzo Gakkai Shi, vol. 37, 1995, pp. 24-28.
Jaffrin, M. Y., et al, “Rationale of Filtration Enhancement in Membrane Plasmapheresis by Pulsatile Blood Flow,” Life Support Systems, vol. 5, 1987, pp. 267-271.
Kobayashi, E., “A Study of Inorganic Ion Exchangers VII; The Synthesis of gammaNH4ZrH(PO4)2 And Ion-Exchange Properties of gamma-NH4Zr(HPO4)2.2H2O,” Bull Chem Soc Jpn, vol. 56, 1983, pp. 3756-3760.
Suri, R, et al, “Adequacy of Quotidian Hemodialysis,” Am J Kidney Dis, vol. 42 Suppl. 1, 2003, pp. S42-S48.
Gotch, F. A., “The Current Place of Urea Kinetic Modelling with Respect to Different Dialysis Modalities,” Nephrol Dial Transplant, vol. 13 Suppl. 6, 1998, pp. 10-14.
Gotch, F. A., et al, “Effective Diffusion Volume Flow Rates (Qe) For Urea, Creatinine, And Inorganic Phosphorous (Qeu, Qecr, QeiP) During Hemodialysis,” Semin Dial, vol. 16, 2003, pp. 474-476.

Affiliated with

Also associated with

Rating

Wearable continuous renal replacement therapy device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Wearable continuous renal replacement therapy device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wearable continuous renal replacement therapy device will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2772881